Literature DB >> 2385876

Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984).

R W Lloyd-Davies1, C D Collins, A V Swan.   

Abstract

The survival of 209 patients with apparently localized carcinoma of the prostate treated by radical external beam radiotherapy is reported, noting the influence of age, stage of the disease at presentation, initial histology, previous surgery, and dose of radiotherapy given. From this it is seen that the development of a six-fraction regimen given over a period of three weeks leads to excellent results whether assessed as a local response or by survival curves and to the economical use of scarce resources, but, even more important, is less wearing for patients than conventional daily fractionation and with no major early or late morbidity recorded up to October 1986.

Entities:  

Mesh:

Year:  1990        PMID: 2385876     DOI: 10.1016/0090-4295(90)80207-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  11 in total

Review 1.  The problem of obstruction in prostate cancer.

Authors:  H P Schmid
Journal:  Urol Res       Date:  1991

2.  Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.

Authors:  Scott C Morgan; Karen Hoffman; D Andrew Loblaw; Mark K Buyyounouski; Caroline Patton; Daniel Barocas; Soren Bentzen; Michael Chang; Jason Efstathiou; Patrick Greany; Per Halvorsen; Bridget F Koontz; Colleen Lawton; C Marc Leyrer; Daniel Lin; Michael Ray; Howard Sandler
Journal:  J Clin Oncol       Date:  2018-10-11       Impact factor: 44.544

3.  Tracing the earliest medical uses of high dose-per-fraction external beam radiation.

Authors:  Brian D Kavanagh
Journal:  J Radiosurg SBRT       Date:  2011

Review 4.  Image-guided focal therapy for prostate cancer.

Authors:  Sandeep Sankineni; Bradford J Wood; Soroush Rais-Bahrami; Annerleim Walton Diaz; Anthony N Hoang; Peter A Pinto; Peter L Choyke; Barış Türkbey
Journal:  Diagn Interv Radiol       Date:  2014-11       Impact factor: 2.630

5.  Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes.

Authors:  Debra E Freeman; Christopher R King
Journal:  Radiat Oncol       Date:  2011-01-10       Impact factor: 3.481

6.  Stereotactic body radiation therapy for prostate cancer patients with old age or medical comorbidity: a 5-year follow-up of an investigational study.

Authors:  Sea-Won Lee; Hong Seok Jang; Jong Hoon Lee; Sung Hwan Kim; Sei Chul Yoon
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

7.  Hypofractionated external-beam radiotherapy for prostate cancer.

Authors:  L Chinsoo Cho; Robert Timmerman; Brian Kavanagh
Journal:  Prostate Cancer       Date:  2013-03-07

8.  Hypofractionated intensity modulated irradiation for localized prostate cancer, results from a phase I/II feasibility study.

Authors:  Sara Junius; Karin Haustermans; Barbara Bussels; Raymond Oyen; Bianca Vanstraelen; Tom Depuydt; Jan Verstraete; Steven Joniau; Hendrik Van Poppel
Journal:  Radiat Oncol       Date:  2007-08-08       Impact factor: 3.481

Review 9.  Hypofractionation in prostate cancer: radiobiological basis and clinical appliance.

Authors:  M Mangoni; I Desideri; B Detti; P Bonomo; D Greto; F Paiar; G Simontacchi; I Meattini; S Scoccianti; T Masoni; C Ciabatti; A Turkaj; S Serni; A Minervini; M Gacci; M Carini; L Livi
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

10.  SHARP hypofractionated stereotactic radiotherapy is well tolerated in prostate cancer : Toxicity and quality of life assessment.

Authors:  Monika Rucinska; Anna Kieszkowska-Grudny; Sergiusz Nawrocki
Journal:  Strahlenther Onkol       Date:  2016-05-25       Impact factor: 3.621

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.